Development of SARS-CoV-2 neutralizing antibody detection assay by using recombinant plant-produced proteins

Hoffmann, 2020, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052 Bergwerk, 2021, Covid-19 breakthrough infections in vaccinated health care workers, N. Engl. J. Med., 385, 1474, 10.1056/NEJMoa2109072 Barnes, 2020, Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies, Cell, 182, 828, 10.1016/j.cell.2020.06.025 Bewley, 2021, Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays, Nat. Protoc., 16, 3114, 10.1038/s41596-021-00536-y Nie, 2020, Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2, Emerg. Microbes Infect., 9, 680, 10.1080/22221751.2020.1743767 Tan, 2020, A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction, Nat. Biotechnol., 38, 1073, 10.1038/s41587-020-0631-z Shanmugaraj, 2020, Plant molecular farming: a viable platform for recombinant biopharmaceutical production, Plants, 9, 10.3390/plants9070842 He, W.; Baysal, C.; Lobato Gómez, M.; Huang, X.; Alvarez, D.; Zhu, C.; Armario-Najera, V.; Blanco Perera, A.; Cerda Bennaser, P.; Saba-Mayoral, A.; et al. Contributions of the international plant science community to the fight against infectious diseases in humans—Part 2: affordable drugs in edible plants for endemic and re-emerging diseases. 2021, 19, 1921–1936, doi: 10.1111/pbi.13658. Lobato Gómez, M.; Huang, X.; Alvarez, D.; He, W.; Baysal, C.; Zhu, C.; Armario-Najera, V.; Blanco Perera, A.; Cerda Bennasser, P.; Saba-Mayoral, A.; et al. Contributions of the international plant science community to the fight against human infectious diseases – part 1: epidemic and pandemic diseases. 2021, 19, 1901–1920, doi: 10.1111/pbi.13657. van Herpen, 2010, Nicotiana benthamiana as a production platform for artemisinin precursors, PLoS ONE, 5, e14222, 10.1371/journal.pone.0014222 Shanmugaraj, 2020, Monoclonal antibodies B38 and H4 produced in Nicotiana benthamiana neutralize SARS-CoV-2 in vitro, Front. Plant Sci., 11 Rattanapisit, 2020, Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana, Sci. Rep., 10, 17698, 10.1038/s41598-020-74904-1 Phakham, 2021, Functional characterization of pembrolizumab produced in Nicotiana benthamiana using a rapid transient expression system, Front. Plant Sci., 12 Moustafa, 2016, Molecular farming on rescue of pharma industry for next generations, Crit. Rev. Biotechnol., 36, 840, 10.3109/07388551.2015.1049934 Shanmugaraj, 2022, Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: protective efficacy, immunogenicity, safety, and toxicity, Vaccine, 40, 4440, 10.1016/j.vaccine.2022.05.087 Shanmugaraj, 2023, Immunogenicity and efficacy of recombinant subunit SARS-CoV-2 vaccine candidate in the Syrian hamster model, Biotechnol. Rep. (Amst), 37, e00779, 10.1016/j.btre.2022.e00779 Mozafari, A.; Kazemi, R.; Amani, J.; Jafari, M.; Salmanian, A.H. Immunogenicity of a plant-derived edible chimeric vaccine candidate against two important enterotoxigenic bacteria in mice model. Mardanova, 2022, High-yield production of chimeric hepatitis E virus-like particles bearing the M2e influenza epitope and receptor binding domain of SARS-CoV-2 in plants using viral vectors, Int. J. Mol. Sci., 23, 15684, 10.3390/ijms232415684 Abolnik, 2022, Efficacy of a plant-produced clade 2.3.4.4 H5 influenza virus-like particle vaccine in layer hens, Vet. Vaccine, 1, 10.1016/j.vetvac.2022.100001 Abdurakhmonov, I.; Buriev, Z.; Shermatov, S.; Usmanov, D.; Mirzakhmedov, M.; Ubaydullaeva, K.; Kamburova, V.; Rakhmanov, B.; Ayubov, M.; Abdullaev, A. The edible tomato COVID-19 vaccine, TOMAVAC, induces neutralising IgGs. 2023. Asghar, 2022, Transient expression of Flavivirus structural proteins in Nicotiana benthamiana, Vaccines (Basel), 10, 1667, 10.3390/vaccines10101667 Shanmugaraj, B.; Bulaon, C.J.I.; Malla, A.; Phoolcharoen, W. Biotechnological insights on the expression and production of antimicrobial peptides in plants. 2021, 26, 4032. Shanmugaraj, B.; Malla, A.; Bulaon, C.J.I.; Phoolcharoen, W.; Phoolcharoen, N. Harnessing the potential of plant expression system towards the production of vaccines for the prevention of human papillomavirus and cervical cancer. 2022, 10, 2064. Bortolami, 2021, Development of a novel assay based on plant-produced infectious bursal disease virus VP3 for the differentiation of infected from vaccinated animals, Front. Plant Sci., 12, 10.3389/fpls.2021.786871 Marques, 2020, Transient expression of dengue virus NS1 antigen in Nicotiana benthamiana for use as a diagnostic antigen, Front. Plant Sci., 10 Rattanapisit, 2021, Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis, Biomater. Transl., 2, 43 Tariq, 2021, Usefulness of ELISA using total antibody against plant-expressed recombinant nucleocapsid protein of SARS-CoV-2, Microbiol. Spectr., 9, 10.1128/Spectrum.00672-21 Siriwattananon, 2021, Plant-produced receptor-binding domain of SARS-CoV-2 elicits potent neutralizing responses in mice and non-human primates, Front. Plant Sci., 12 Diamos, 2018, Modifying the replication of geminiviral vectors reduces cell death and enhances expression of biopharmaceutical proteins in Nicotiana benthamiana leaves, Front. Plant Sci., 9, 1974, 10.3389/fpls.2018.01974 Chen, 2011, Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants, Hum. Vaccin., 7, 331, 10.4161/hv.7.3.14262 Wu, 2020, A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2, Science, 368, 1274, 10.1126/science.abc2241 Tian, 2020, Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody, Emerg. Microbes Infect., 9, 382, 10.1080/22221751.2020.1729069 Bloom, 2019, Infectious disease threats in the twenty-first century: strengthening the global response, Front. Immunol., 10 World Health Organization. COVID-19 vaccine tracker and landscape. Available online: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines (accessed on 24 Feb 2023). Amanat, 2020, A serological assay to detect SARS-CoV-2 seroconversion in humans, Nat. Med., 26, 1033, 10.1038/s41591-020-0913-5 Kitagawa, 2022, Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test, J. Med. Virol., 94, 335, 10.1002/jmv.27338 Taylor, 2021, A new SARS-CoV-2 dual-purpose serology test: highly accurate infection tracing and neutralizing antibody response detection, J. Clin. Microbiol., 59, 10.1128/JCM.02438-20 Valcourt, 2021, Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), Diagn. Microbiol. Infect. Dis., 99, 10.1016/j.diagmicrobio.2020.115294 Mariën, 2021, Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2, J. Virol. Methods, 297, 10.1016/j.jviromet.2021.114228 Pieri, 2022, Performance evaluation of four surrogate virus neutralization tests (sVNTs) in comparison to the in vivo gold standard test, FBL, 27 Perera, 2021, Evaluation of a SARS-CoV-2 surrogate virus neutralization test for detection of antibody in human, canine, cat, and hamster sera, J. Clin. Microbiol., 59, e02504, 10.1128/JCM.02504-20 Lynch, 2022, Evaluation of neutralizing antibodies against SARS-CoV-2 variants after infection and vaccination using a multiplexed surrogate virus neutralization test, Clin. Chem., 68, 702, 10.1093/clinchem/hvab283